Pgff.Pk
PGFF.PK operates in the healthcare sector, specifically in the pharmaceuticals activity, and generates revenue through the provision of healthcare facilities and services.
Business. PGFF.PK operates in the healthcare sector, specifically in the pharmaceuticals activity, and generates revenue through the provision of healthcare facilities and services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
PGFF.PK operates in the healthcare sector, specifically in the pharmaceuticals activity, and generates revenue through the provision of healthcare facilities and services.
PGFF.PK exhibits a severely strained capital structure, with total liabilities of $1.2 billion and total equity of -$612.2 million, resulting in a negative debt-to-equity ratio of -0.98. The company's liquidity position is extremely weak, as evidenced by a current ratio of 0.03 and only $630 in cash and equivalents. The negative operating and free cash flows of -$348.8 million and -$394.3 million, respectively, further underscore the company's inability to generate cash from operations.
Profitability metrics are deeply negative, with a net loss of -$403.4 million and an operating loss of -$390.7 million. The return on assets of -6.81% indicates that the company is not generating returns from its asset base. The return on equity of 65.89% is misleading due to the negative equity base, and should not be interpreted as a positive performance indicator.
The company's revenue is not segmented by geographic region or business line in the available data, making it difficult to assess revenue concentration or diversification. The lack of segment data also limits the ability to evaluate the performance of different parts of the business.
The company's growth trajectory is not clearly defined due to the absence of historical revenue data and forward-looking guidance. The negative operating and free cash flows suggest a lack of financial flexibility and potential operational challenges.
The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, highlighting the need for close monitoring of its liquidity and capital structure. The low dilution risk suggests that the company is not currently issuing shares at a rate that would significantly dilute existing shareholders.
Recent events and filings are not detailed in the available data, limiting the ability to assess the company's recent performance and strategic direction. The absence of recent transcripts or filings makes it difficult to evaluate management's outlook or any material developments.
- PGFF.PK has a severely negative net income and operating income, indicating significant financial distress.
- The company's liquidity position is extremely weak, with a current ratio of 0.03 and minimal cash reserves.
- The return on equity is misleadingly high due to the negative equity base and should not be interpreted as a positive performance metric.
- The company's capital structure is highly leveraged, with total liabilities exceeding total assets.
- There is a lack of segment and geographic data, making it difficult to assess the company's diversification and risk exposure.
- The company's growth trajectory is unclear due to the absence of historical revenue data and forward-looking guidance.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- PGFF.PK Market data — financials · 2026-05-28